Anna Usacheva

585 total citations
17 papers, 467 citations indexed

About

Anna Usacheva is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Anna Usacheva has authored 17 papers receiving a total of 467 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Oncology and 4 papers in Pharmacology. Recurrent topics in Anna Usacheva's work include Cytokine Signaling Pathways and Interactions (7 papers), interferon and immune responses (3 papers) and Genomics, phytochemicals, and oxidative stress (3 papers). Anna Usacheva is often cited by papers focused on Cytokine Signaling Pathways and Interactions (7 papers), interferon and immune responses (3 papers) and Genomics, phytochemicals, and oxidative stress (3 papers). Anna Usacheva collaborates with scholars based in Russia, United States and Switzerland. Anna Usacheva's co-authors include Oscar R. Colamonici, Sergey V. Gudkov, A. V. Chernikov, В. И. Брусков, Ed Croze, Sergei V. Kotenko, В. Е. Иванов, Raudel Sandoval, Paul Domanski and Gleb Baida and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and Journal of Photochemistry and Photobiology B Biology.

In The Last Decade

Anna Usacheva

17 papers receiving 459 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Usacheva Russia 12 164 153 148 43 39 17 467
Biplab Bose India 14 215 1.3× 50 0.3× 50 0.3× 59 1.4× 62 1.6× 31 452
Feng Shan China 13 187 1.1× 163 1.1× 187 1.3× 13 0.3× 51 1.3× 20 572
Malcolm A. King Australia 15 468 2.9× 90 0.6× 148 1.0× 19 0.4× 34 0.9× 21 755
Kay O. Broschat United States 13 504 3.1× 82 0.5× 56 0.4× 31 0.7× 26 0.7× 16 794
E J Beecham United States 7 389 2.4× 146 1.0× 192 1.3× 38 0.9× 34 0.9× 10 661
Heyi Yang United States 10 359 2.2× 197 1.3× 42 0.3× 15 0.3× 15 0.4× 21 594
Pey Yee Lee Malaysia 11 360 2.2× 43 0.3× 65 0.4× 23 0.5× 33 0.8× 18 542
Tamara Kanashova Germany 9 333 2.0× 53 0.3× 63 0.4× 13 0.3× 38 1.0× 10 511
Zilu Ye Denmark 15 546 3.3× 130 0.8× 44 0.3× 75 1.7× 37 0.9× 34 675

Countries citing papers authored by Anna Usacheva

Since Specialization
Citations

This map shows the geographic impact of Anna Usacheva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Usacheva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Usacheva more than expected).

Fields of papers citing papers by Anna Usacheva

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Usacheva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Usacheva. The network helps show where Anna Usacheva may publish in the future.

Co-authorship network of co-authors of Anna Usacheva

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Usacheva. A scholar is included among the top collaborators of Anna Usacheva based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Usacheva. Anna Usacheva is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Chernikov, A. V., et al.. (2023). Metformin counters oxidative stress and mitigates adverse effects of radiation exposure: An overview. Fundamental and Clinical Pharmacology. 37(4). 713–725. 3 indexed citations
2.
Usacheva, Anna, et al.. (2022). Pharmacological Aspects of the Use of Lipoic Acid (Review). Pharmaceutical Chemistry Journal. 55(11). 1138–1146. 7 indexed citations
3.
Брусков, В. И., et al.. (2021). Formation of Hydrated Electrons in Water under Thermal Electromagnetic Exposure. Physics of Wave Phenomena. 29(2). 94–97. 8 indexed citations
4.
Chernikov, A. V., et al.. (2020). Antioxidant and Gene-Protective Properties of Ethylmethylhydroxypyridine Succinate (Mexidol) in X-Ray Irradiation. Pharmaceutical Chemistry Journal. 54(7). 673–677. 6 indexed citations
5.
Chernikov, A. V., Sergey V. Gudkov, Anna Usacheva, & В. И. Брусков. (2017). Exogenous 8-oxo-7,8-dihydro-2′-deoxyguanosine: Biomedical properties, mechanisms of action, and therapeutic potential. Biochemistry (Moscow). 82(13). 1686–1701. 21 indexed citations
6.
Иванов, В. Е., Anna Usacheva, A. V. Chernikov, В. И. Брусков, & Sergey V. Gudkov. (2017). Formation of long-lived reactive species of blood serum proteins induced by low-intensity irradiation of helium-neon laser and their involvement in the generation of reactive oxygen species. Journal of Photochemistry and Photobiology B Biology. 176. 36–43. 33 indexed citations
7.
Смирнов, В. С., Anna Usacheva, Alexey V. Berezhnov, et al.. (2013). Pro-oxidative, genotoxic and cytotoxic properties of uranyl ions. Journal of Environmental Radioactivity. 127. 163–170. 38 indexed citations
8.
Usacheva, Anna, et al.. (2012). Protection of Mice against X-ray Injuries by the Post-irradiation Administration of Inosine-5'-monophosphate. Journal of Radiation Research. 53(2). 211–216. 11 indexed citations
9.
Usacheva, Anna, et al.. (2010). Antioxidative and Radiation Modulating Properties of Guanosine-5′-Monophosphate. Nucleosides Nucleotides & Nucleic Acids. 29(10). 786–799. 19 indexed citations
10.
Gudkov, Sergey V., et al.. (2007). Guanosine and inosine (riboxin) eliminate the long-lived protein radicals induced X-ray radiation. Doklady Biochemistry and Biophysics. 413(1). 50–53. 38 indexed citations
11.
Usacheva, Anna, et al.. (2003). The WD Motif-Containing Protein RACK-1 Functions as a Scaffold Protein Within the Type I IFN Receptor-Signaling Complex. The Journal of Immunology. 171(6). 2989–2994. 25 indexed citations
12.
Usacheva, Anna, Raudel Sandoval, Paul Domanski, et al.. (2002). Contribution of the Box 1 and Box 2 Motifs of Cytokine Receptors to Jak1 Association and Activation. Journal of Biological Chemistry. 277(50). 48220–48226. 46 indexed citations
13.
Usacheva, Anna, Sergei V. Kotenko, Michael M. Witte, & Oscar R. Colamonici. (2002). Two Distinct Domains Within the N-Terminal Region of Janus Kinase 1 Interact with Cytokine Receptors. The Journal of Immunology. 169(3). 1302–1308. 29 indexed citations
14.
Kurnasov, Oleg V., Anna Usacheva, Brian A. Hemmings, et al.. (2001). Phosphatidylinositol 3-Kinase Confers Resistance to Encephalomyocarditis and Herpes Simplex Virus-Induced Cell Death Through the Activation of Distinct Downstream Effectors. The Journal of Immunology. 167(8). 4553–4559. 23 indexed citations
16.
Croze, Ed, Anna Usacheva, David M. Asarnow, et al.. (2000). Receptor for Activated C-Kinase (RACK-1), a WD Motif-Containing Protein, Specifically Associates with the Human Type I IFN Receptor. The Journal of Immunology. 165(9). 5127–5132. 45 indexed citations
17.
Nadeau, Owen W., Paul Domanski, Anna Usacheva, et al.. (1999). The Proximal Tyrosines of the Cytoplasmic Domain of the β Chain of the Type I Interferon Receptor Are Essential for Signal Transducer and Activator of Transcription (Stat) 2 Activation. Journal of Biological Chemistry. 274(7). 4045–4052. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026